Primary Light-Chain Amyloidosis

1

Review clinical trials related to Primary Light-Chain Amyloidosis. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Study Evaluating the Efficacy and Safety of CM336 Injection in the Treatment of Light-Chain Amyloidosis

to Evaluate the Efficacy and Safety of CM336 (BCMA/CD3 Bispecific Antibody) in Adults with Relapsed or Refractory Primary Light-Chain Amyloidosis

Participants needed: 90
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Keymed Biosciences Co.LtdUpdated: Nov 26, 2025Locations: 2
Eligibility criteria

Voluntary provision of written informed consent and ability to comply with proto... [+7]

Current or prior diagnosis of multiple myeloma. [+4]